One of the key components of MetS is insulin resistance and the genetic variants identified in the longevity meta-analysis for Klotho, IL6 and FOXO3A inhibit the insulin/IGF-1 signalling pathway [16–18]. This evidence concerns the gene IL6 and metabolic syndrome.